Ellen O'Connor Vos - Mar 30, 2022 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role: Director
Signature: /s/ Lynn O'Connor Vos
Stock symbol: OPRX
Transactions as of: Mar 30, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/1/2022, 04:46 PM
Previous filing: Jan 3, 2022
Next filing: Jun 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OPRX	Restricted Stock Units	Award	$0	+657		$0.00	657	Mar 30, 2022	Common Stock	657		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
F2	The restricted stock units vest on March 30, 2023.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.